Inside the FDA's vaccine uproar

A recent memo from Dr. Vinay Prasad​, the head of the FDA's Center for Biologics Evaluation and Research, may signal an ...
STAT

FDA voucher program has become vehicle for political interference in drug review decisions, staffers say

Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...

Rx inspector: ProPublica’s new tool provides drug info the FDA won’t

Today, ProPublica is launching Rx Inspector, a first-of-its-kind database that provides answers to what the FDA won’t tell us ...

FDA adds brain tumor warning to Depo-Provera birth control shot

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot ...

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

Recalled formula is still on shelves. The FDA is warning retailers.

The recalled formula, ByHeart Baby Formula, has been linked to 51 cases of confirmed or suspected infant botulism.

Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers

The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with ...

Louisiana joins Florida and Texas in challenging FDA policy over mifepristone

Louisiana Attorney General Liz Murrill on Wednesday led her state in becoming the latest to challenge the government’s ...
Opinion
Physicians Committee for Responsible MedicineOpinion

Making Animal Experiments the Exception: The Physicians Committee’s Road to FDA Reform

In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...
The Texas Tribune on MSN

Texas, Florida sue FDA over abortion pill approval

Seeking to pull mifepristone from the drug market, the states argued that the FDA did not properly evaluate the pill’s safety ...
Healthline

FDA OKs Addyi, a Libido-Enhancing Drug for Women After Menopause

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...
ConsumerAffairs

FDA warns Walmart, Target and Kroger over recalled baby formula still on shelves

FDA says major retailers continued selling recalled infant formula linked to a first-ever U.S. botulism outbreak ByHeart ...